153 related articles for article (PubMed ID: 28431339)
1. Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells.
Zwergel C; Czepukojc B; Evain-Bana E; Xu Z; Stazi G; Mori M; Patsilinakos A; Mai A; Botta B; Ragno R; Bagrel D; Kirsch G; Meiser P; Jacob C; Montenarh M; Valente S
Eur J Med Chem; 2017 Jul; 134():316-333. PubMed ID: 28431339
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases.
Valente S; Bana E; Viry E; Bagrel D; Kirsch G
Bioorg Med Chem Lett; 2010 Oct; 20(19):5827-30. PubMed ID: 20800482
[TBL] [Abstract][Full Text] [Related]
3. A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death.
Bana E; Sibille E; Valente S; Cerella C; Chaimbault P; Kirsch G; Dicato M; Diederich M; Bagrel D
Mol Carcinog; 2015 Mar; 54(3):229-41. PubMed ID: 24155226
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
[TBL] [Abstract][Full Text] [Related]
5. Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells.
Saidu NE; Valente S; Bana E; Kirsch G; Bagrel D; Montenarh M
Bioorg Med Chem; 2012 Feb; 20(4):1584-93. PubMed ID: 22264758
[TBL] [Abstract][Full Text] [Related]
6. Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.
Capasso A; Cerchia C; Di Giovanni C; Granato G; Albano F; Romano S; De Vendittis E; Ruocco MR; Lavecchia A
Oncotarget; 2015 Nov; 6(37):40202-22. PubMed ID: 26474275
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties.
Rizzk YW; El-Deen IM; Mohammed FZ; Abdelhamid MS; Khedr AIM
Anticancer Agents Med Chem; 2019; 19(16):2010-2018. PubMed ID: 31566140
[TBL] [Abstract][Full Text] [Related]
8. Novel acyclic enediynes inhibit Cyclin A and Cdc25C expression and induce apoptosis phenomenon to show potent antitumor proliferation.
Lo YH; Lin IL; Lin CF; Hsu CC; Yang SH; Lin SR; Wu MJ
Bioorg Med Chem; 2007 Jul; 15(13):4528-36. PubMed ID: 17485212
[TBL] [Abstract][Full Text] [Related]
9. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.
Jing L; Wu G; Hao X; Olotu FA; Kang D; Chen CH; Lee KH; Soliman MES; Liu X; Song Y; Zhan P
Eur J Med Chem; 2019 Dec; 183():111696. PubMed ID: 31541869
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers.
Tseng CH; Tzeng CC; Hsu CY; Cheng CM; Yang CN; Chen YL
Eur J Med Chem; 2015 Jun; 97():306-19. PubMed ID: 26005780
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.
Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P
Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
13. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.
Lazo JS; Aslan DC; Southwick EC; Cooley KA; Ducruet AP; Joo B; Vogt A; Wipf P
J Med Chem; 2001 Nov; 44(24):4042-9. PubMed ID: 11708908
[TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate.
Song Y; Lin X; Kang D; Li X; Zhan P; Liu X; Zhang Q
Eur J Med Chem; 2014 Jul; 82():293-307. PubMed ID: 24922544
[TBL] [Abstract][Full Text] [Related]
15. Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells.
Brault L; Bagrel D
Life Sci; 2008 Jan; 82(5-6):315-23. PubMed ID: 18191419
[TBL] [Abstract][Full Text] [Related]
16. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis.
Chen JS; Lin SY; Tso WL; Yeh GC; Lee WS; Tseng H; Chen LC; Ho YS
Mol Carcinog; 2006 Jul; 45(7):461-78. PubMed ID: 16649252
[TBL] [Abstract][Full Text] [Related]
18. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
[TBL] [Abstract][Full Text] [Related]
19. CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.
Lavecchia A; Di Giovanni C; Novellino E
Curr Med Chem; 2009; 16(15):1831-49. PubMed ID: 19442149
[TBL] [Abstract][Full Text] [Related]
20. Synthetic small molecule Cdc25 phosphatases inhibitors.
Garuti L; Roberti M; Pizzirani D
Curr Med Chem; 2008; 15(6):573-80. PubMed ID: 18336271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
